May 15, 2024Open Access

Comparison of Glycated Haemoglobin with Coagulation and Biochemical Profile of Patients with Type II Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

Authors

SASamuel Antwi‐BaffourLondon Metropolitan University BMBenjamin Tetteh MensahUniversity of Ghana DADorinda Naa Okailey ArmahUniversity of Ghana

Discussion

Member takes

Implication

Comparative analysis reveals hypercoagulability and elevated systolic blood pressure in poorly controlled type II diabetes patients, suggesting an increased risk of thrombosis.

Key Points

Poor glycemic control shortens activated partial thromboplastin time and prothrombin time, which drives prothrombotic coagulation states in type II diabetes mellitus patients.
Patients with glycated haemoglobin at or above 6.5 demonstrated shorter clotting times, whereas fibrinogen and D-dimer were increased across all 150 diabetic participants.
Analysis of automated coagulation and chemistry profiles indicates that persistent hyperglycaemia promotes thrombosis risk through activated prothrombotic factors.

Cite This Study

Antwi‐Baffour et al. (2024) studied this question.

synapsesocial.com/papers/68e6a006b6db643587623ffa https://doi.org/10.21203/rs.3.rs-4378442/v1

View Full Paper

Ask AI

Bookmark

Implication

Comparative analysis reveals hypercoagulability and elevated systolic blood pressure in poorly controlled type II diabetes patients, suggesting an increased risk of thrombosis.

Comparison of Glycated Haemoglobin with Coagulation and Biochemical Profile of Patients with Type II Diabetes Mellitus

Discussion

Member takes

Implication

Key Points

Cite This Study

Comparison of Glycated Haemoglobin with Coagulation and Biochemical Profile of Patients with Type II Diabetes Mellitus

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider